Autism Spectrum Disorders:
Research and Medical Treatment Implications Series

Webcasts

Genetics and Autism Spectrum Disorder – Part One
Marvin Natowicz, MD, PhD; Steve Scherer, PhD

Release date: October 4, 2019
Renew date: October 4, 2022
Expiration date: October 4, 2022
Estimated Time: 45 minutes
Type:  Webcast

Technical Requirements: none
Specialties:Family Practice; Neurology; Pathology; Pediatrics

Genetics and Autism Spectrum Disorder – Part Two
Marvin Natowicz, MD, PhD; Steve Scherer, PhD

Release date: October 4, 2019
Renew date: October 4, 2022
Expiration date: October 4, 2022
Estimated Time: 45 minutes
Type:  Webcast

Technical Requirements: none
Specialties:Family Practice; Neurology; Pathology; Pediatrics

Psychiatric Issues and Autism Spectrum Disorder 
Robert Hendren, DO; Charles Henry, MD; Agnes Whitaker, MD; Facilitated by Marvin Natowicz, MD, PhD

Release date: October 4, 2019
Renew date: October 4, 2022
Expiration date: October 4, 2022
Estimated Time: 45 minutes
Type:  Webcast

Technical Requirements: none
Specialties:Family Practice; Neurology; Pediatrics; Psychology / Psychiatry

Psychopharmacology and Autism Spectrum Disorder 
Robert Hendren, D.O., Charles Henry, MD, Agnes Whitaker, MD; Facilitated by Marvin Natowicz, MD, PhD

Release date: October 4, 2019
Expiration date: October 4, 2021
Renew date: October 4, 2022
Estimated Time: 45 minutes
Type:  Webcast

Technical Requirements: none
Specialties: Family Practice; Neurology; Pediatrics; Psychology / Psychiatry

Watch Epilepsy and Autism Spectrum Disorders Series

Series Learning Objectives

1. Recognize the relevance of genetics in a discussion of autism pathobiology
2. Recognize types of genetic variations that are observed—including various single gene and cytogenomic differences
3. Recognize different approaches that have been used to establish that there are genetic factors that are relevant to autism causation
4. Recognize some of the important clinical tests used to evaluate possible genetic factors in autism causation
5. Discuss unsolved issues with respect to genetic dimensions of autism
6. Recognize the major medical comorbidities that occur with ASD
7. Recognize the major neurological comorbidities that occur with ASD
8. Examine various aspects of pharmacologic treatments, including: When medications might or should be used, strengths and limitations of medical treatment for comorbidities, potential side effects.
9. Review the current clinical definition of autism in a child or adult
10. Examine how autism has changed over time and critiques of different notions of ASD
11. Describe common psychiatric comorbidities seen in ASD, their frequency and how they affect quality of life
12. Recognize the impact ASD has on the individual family systems

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Cleveland Clinic Foundation Center for Continuing Education and the Autism Research Institute. The Cleveland Clinic Foundation Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

This online series is designed for a primary audience of pediatricians, family practice physicians, psychiatrists, gastroenterologists, endocrinologists, neurologists, medical geneticists and allied health practitioners. The secondary audience includes internists, nutritionists and associated allied health practitioners interested in underlying medical and neurological comorbidities associated with autism spectrum disorders.

Activity Director

Marvin Natowicz, MD, PhD
Clinical Geneticist, Clinical Pathologist
Pathology & Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH